(Press-News.org) Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet in Sweden report in a study published in the scientific journal Cell Host & Microbe.
During last year’s mpox outbreak, the virus spread for the first time outside Africa, causing over 85,000 cases of the disease to date. Men who have sex with men account for the most infections, with a marked skew towards the young.
The virus that causes mpox is what is known as an orthopoxvirus and is very similar to the virus that caused smallpox until the mid-1970s when it was finally eradicated.
Since there were data indicating that the old smallpox vaccine could protect against mpox, the researchers at Karolinska Institutet wondered if the individuals who were vaccinated decades ago against the former would have some protection against the latter owing to a remaining memory response.
“Our study shows that this is the case, which implies that the memory cells are very long-lived and that they can recognise closely related viruses such as the mpox virus and provide overlapping, or cross-reactive immunity,” says the study’s corresponding author Marcus Buggert, docent and researcher at the Center for Infectious Medicine, Karolinska Institutet.
By analysing the T-cell immune response in 105 healthy blood donors, the researchers were able to show that individuals born before 1976 had a significantly stronger immune response against both viral types. The researchers also analysed the immune response in 22 men with a recent mpox infection and showed that they also exhibited a strong immune response to the virus, which may provide future immunity.
The current study was too small to judge how much protection previous smallpox vaccination provides, but Dr. Buggert refers to a recently published British observational study examining the effect of a smallpox vaccine given to risk-group males in 2022.
“This study shows that smallpox vaccine can provide about 80 percent protection against mpox,” he says.
The study was financed by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the ERC, Karolinska Institutet, the Swedish Society for Medical Research (SSMF), the Swedish Cancer Society, the Åke Wiberg Foundation, the Magnus Bergvall Foundation and the Jonas Söderquist Foundation.
Marcus Buggert is a consultant for Oxford Immunotec, Mabtech, BMS and MSD.
Facts about mpox:
Mpox (formerly monkeypox) is a viral infection spread mainly through close physical contact with an infected person. Physical sexual contact poses a particularly high risk. Common symptoms are blistering, sores and rashes, fever, and swollen glands. It can also cause pain and discomfort but typically clears up on its own after two to four weeks.
In Sweden, the smallpox vaccination programme started in the early 19th century and was discontinued in 1976 when the disease was eradicated. The vaccine was mandatory for the entire population.
The vaccine currently given for mpox is essentially a smallpox vaccine.
Source: The Swedish Public Health Agency.
Publication: “Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox”. Sarah Adamo, Yu Gao, Takuya Sekine, Akhirunnesa Mily, Jinghua Wu, Elisabet Storgärd, Victor Westergren, Finn Filén, Carl-Johan Treutiger, Johan K. Sandberg, Matti Sällberg, Peter Bergman, Sian Llewellyn-Lacey, Hans-Gustaf Ljunggren, David A. Price, Anna-Mia Ekström, Alessandro Sette, Alba Grifoni, Marcus Buggert. Cell Host & Microbe, online 25 April 2023 (In Press, Journal Pre-Proof), doi: 10.1016/j.chom.2023.04.015.
END
Previous smallpox vaccine provides immunity to mpox
2023-05-23
ELSE PRESS RELEASES FROM THIS DATE:
Fever found to be most common non-respiratory feature of SARS-CoV-2 infection
2023-05-23
Session: C58, Health Services Research in Diverse Settings
Date and Time: 11:30 a.m. ET, Tuesday, May 23, 2023
Location: WEWCC, Area 1, Hall C (Lower Level)
ATS 2023, Washington, DC – Fever was found to be the most common non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19, according to research published at the ATS 2023 International Conference. The finding held true regardless of which COVID variant patients had, and whether or not they were fully vaccinated or not fully vaccinated. The researchers, who also looked at mortality risk, found that patients who were ...
International group of experts redefines concussions
2023-05-23
Doctors and other health-care providers have a new standard for diagnosing mild traumatic brain injury (TBI), thanks to a thorough process led by researchers from the University of B.C. and Harvard-affiliated Spaulding Rehabilitation Hospital.
"We've achieved consensus across a diverse range of experts in developing these new diagnostic criteria,” said Dr. Noah Silverberg, associate professor in UBC’s department of psychology, member of the Djavad Mowafaghian Centre for Brain Health and Centre for Aging SMART at Vancouver Coastal Health, and co-lead of the project. “Our ...
USC Health System Board appoints Paul B. Rothman, MD, as board member
2023-05-23
LOS ANGELES — Paul B. Rothman, MD, has been appointed as a member of the USC Health System Board, which provides strategic oversight and governance over Keck Medicine of USC and university clinical services.
Rothman, former CEO of Johns Hopkins Medicine and retired dean of medical faculty for the Johns Hopkins University School of Medicine, brings his leadership acumen as well as clinical and scientific expertise in rheumatology and molecular immunology to this advisory role.
“Paul ...
Diagnosis of type 1 diabetes after SARS-CoV-2 infection: Researchers find possible correlation
2023-05-23
Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic. However, none of the studies distinguishes between children with and without SARS-CoV-2 infection. Researchers were now able to gain new insights: the KVB data set provides information on whether children diagnosed with type 1 diabetes previously had COVID-19. This allows an analysis of the temporal relationship between a COVID-19 diagnosis and the diagnosis of type 1 diabetes. Amongst the analyzed children without ...
RPI and Albany Medical College researchers awarded $3.3 million to improve breast cancer treatment using artificial intelligence
2023-05-23
Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes.
The research is being led by Xavier Intes, Rensselaer professor of biomedical engineering and co-director of the Center for Modeling, Simulation and Imaging in Medicine, and ...
Element creation in the lab deepens understanding of surface explosions on neutron stars
2023-05-23
Led by Kelly Chipps of the Department of Energy’s Oak Ridge National Laboratory, scientists working in the lab have produced a signature nuclear reaction that occurs on the surface of a neutron star gobbling mass from a companion star. Their achievement improves understanding of stellar processes generating diverse nuclear isotopes.
“Neutron stars are really fascinating from the points of view of both nuclear physics and astrophysics,” said ORNL nuclear astrophysicist Kelly Chipps, who led a study published in Physical Review Letters. “A deeper understanding of their dynamics may help reveal the cosmic ...
New treatment helps people stop addictive opioid painkillers used for chronic pain
2023-05-23
Programme of combined one-to-one and group support sessions was tested in landmark clinical trial
After one year, one in five people were able to stop taking opioids without their pain increasing
Experts say the new treatment is an alternative to opioid use and has potential to give patients better quality of life
Researchers at the University of Warwick and The James Cook University Hospital, Middlesbrough have led a clinical trial, funded by the National Institute for Health and Care Research (NIHR), on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain.
There are over 1 ...
CT scan best at predicting heart disease risk in middle age
2023-05-23
CHICAGO ---CT scans are better at predicting a middle-aged person’s risk for a heart disease, such as a heart attack, than genetics, reports a new Northwestern Medicine study.
“Finding the best way to identify who is at risk for developing heart disease can help determine what needs to be done to lower their risk,” said lead study author Dr. Sadiya Khan, an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine cardiologist. “This finding can help doctors and patients in managing risk for heart disease, which is the leading cause ...
Study: Transcatheter mitral valve repair safe, successful
2023-05-23
Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral valves revealed the minimally invasive procedure to be safe and effective in nearly 90% of patients, according to Cedars-Sinai physician-scientists.
Their findings on the condition called degenerative mitral regurgitation were published today in the peer-reviewed Journal of the American Medical Association (JAMA), representing the largest study to date that examines outcomes for patients treated outside of a clinical trial with transcatheter edge-to-edge repair (TEER).
“Treatment was successful in nearly nine out of every 10 patients in whom TEER was used to repair ...
Artificial pancreas reduces disease management burden for people with diabetes
2023-05-23
WASHINGTON, May 23, 2023 – Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily injections to avoid peripheral diseases caused by extremes of high or low blood sugar.
Automated insulin delivery systems, also called artificial pancreases, make diabetes management much less onerous for patients. These systems — with implanted insulin sensors, pumps that ...